Skip to main content

Making Us Wait: The Nobel Prize in Literature

Image result for philip rahv

I went to bed Wednesday night, October 5, believing that there was a reasonable chance that, when I awoke, Philip Roth would at last have won a Nobel Prize in Literature.

This was a mistake. The first problem was the scheduling. The Prizes are usually announced over the course of a single week, one announcement per day, and in the 'natural' course of events, the Lit Prize would have been announced after each of the 'hard sciences' on the list" medicine, physics, chemistry, had had its turn in the spotlight. So, that would have been last Thursday.

Unbeknowst to me, though, the Lit panel had announced back in September, before I was paying attention, that it was taking longer than usual to make its decision, and that it would not bestow its prize this year until the Thursday after everybody else had bestowed the others.

Maybe they're tired of always coming in the middle, after the hard sciences, before the Huge Publicity events of Peace and Economics. Maybe this is a publicity gimmick to finally be the ones that wrap up Oscar season, or the egghead analog thereto.

I believed, and still believe, that Roth is deserving. As a caveat, allow me to say that my personal favorite near-contemporary novelist, John Updike, has passed on.  So, under the rules, he is no longer eligible.

But back to Roth. Far more than the non-entities that have received the prize in some recent years, more so even than Pearl S. Buck, who won the Prize in 1938 for THE GOOD EARTH. Buck was not a non-entity, but the figure she cuts seems smaller as the decades move by. In this respect she is more like Philip Rahv than Philip Roth. (That's Rahv, portrayed above.)

One point that strikes me about Roth is personal to me. He was born in March 1933. My father, Clinton James Faille, was also born in that month and year as well. Dad has been gone since June 2003, and it is good to see notable people of the same cohort surviving, and thriving.

The second problem with my view on the evening of October 5th of course was that when the  award came down, this morning, the winner was ... Bob Dylan.

Good for him, but that is a surprise, given the usual novel-based focus of the awards panel. And Roth will have to wait for another year.


Popular posts from this blog

England as a Raft?

In a lecture delivered in 1880, William James asked rhetorically, "Would England ... be the drifting raft she is now in European affairs if a Frederic the Great had inherited her throne instead of a Victoria, and if Messrs Bentham, Mill, Cobden, and Bright had all been born in Prussia?"

Beneath that, in a collection of such lectures later published under James' direction, was placed the footnote, "The reader will remember when this was written."

The suggestion of the bit about Bentham, Mill, etc. is that the utilitarians as a school helped render England ineffective as a European power, a drifting raft.

The footnote was added in 1897. So either James is suggesting that the baleful influence of Bentham, Mill etc wore off in the meantime or that he had over-estimated it.

Let's unpack this a bit.  What was happening in the period before 1880 that made England seem a drifting raft in European affairs, to a friendly though foreign observer (to the older brother…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Francesco Orsi

I thought briefly that I had found a contemporary philosopher whose views on ethics and meta-ethics checked all four key boxes. An ally all down the line.

The four, as regular readers of this blog may remember, are: cognitivism, intuitionism, consequentialism, pluralism. These represent the views that, respectively: some ethical judgments constitute knowledge; one important source for this knowledge consists of quasi-sensory non-inferential primary recognitions ("intuitions"); the right is logically dependent upon the good; and there exists an irreducible plurality of good.

Francesco Orsi seemed to believe all of these propositions. Here's his website and a link to one relevant paper:

What was better: Orsi is a young man. Born in 1980. A damned child! Has no memories of the age of disco!

So I emailed him asking if I was right that he believed all of those things. His answer: three out of …